Market Overview

FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump

FBR Capital Markets initiated coverage on shares of TherapeuticsMD (NYSE: TXMD) with an “outperform” rating.

The target price for TherapeuticsMD is set to $34.

TherapeuticsMD shares have jumped 54.10% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.

TherapeuticsMD's shares jumped 32.93% to $5.49 in pre-market trading.

Posted-In: FBR Capital MarketsInitiation Analyst Ratings

 

Related Articles (TXMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters